Home » Topics » Regulatory

Regulatory
RSS

Once-weekly Enbrel approved

Oct. 23, 2003

Lexiva, the only protease inhibitor offering flexible dosing, approved in U.S.

Oct. 22, 2003

Paxil CR approved for social anxiety disorder

Oct. 22, 2003

FDA accepts for filing NDA for ultra-low-dose transdermal estrogen patch

Oct. 20, 2003

PEG-Intron Redipen approved by FDA

Oct. 15, 2003

Betaseron prefilled diluent syringe receives FDA approval

Oct. 15, 2003

Seroquel approved in Europe for bipolar mania

Oct. 15, 2003

Approval for prefilled syringe presentation of Ovidrel

Oct. 14, 2003

Inspra approved for congestive heart failure in heart attack patients

Oct. 13, 2003

Abbott seeks approval for Humira for improvement of physical function in RA

Oct. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...